Sleepiness: all 168 studies
Page 2 of 2. Open to participants first (20), then studies with results posted, then the rest; newest registration first within each.
- Community-Level Daytime Sleepiness: Social-Environmental Determinants, Consequences, and Impact of Sleep ApneaCompletedNCT04176042Not applicable
- Obstructive Sleep Apnoea in SarcoidosisCompletedNCT04156789
- Study of TAK-925 in Participants With Obstructive Sleep Apnea (OSA) Who Are Experiencing Excessive Daytime Sleepiness (EDS) Despite Adequate Use of Continuous Positive Airway Pressure (CPAP)CompletedNCT04091425Phase 1
- Start Times and Restful SleepWithdrawnNCT04049682
- Sleepiness and Tiredness Among Doctors Working in A Tertiary HospitalCompletedNCT04020991
- Chronic Non-inflammatory Pains in RheumatopediatricsWithdrawnNCT03740347
- Internal and Predictive Validity of Epworth Sleepiness Scale to Evaluate Vigilance of Patient Treated for Obstructive Sleep Apnea Syndrome.CompletedNCT03629834
- Cognitive Assessment in Excessive Daytime Sleepiness: Electrophysiological Study.CompletedNCT03446066
- Expanded Access Program to Provide Treatment With Pitolisant to Adult Patients in the U.S. With Excessive Daytime Sleepiness Associated With Narcolepsy With or Without CataplexyNo longer availableNCT03433131
- Donepezil, Residual Excessive Daytime Sleepiness, Obstructive Sleep ApneaStatus unknownNCT03299257Phase 4
- Nutrients to Enhance Sleep Quality and QuantityCompletedNCT03288077Not applicable
- Biomarkers of Insufficient Sleep and SleepinessCompletedNCT03130803Not applicable
- Effect of Strength Training on the Quality and Duration of Sleep and Daytime Sleepiness of Institutionalized AdolescentsCompletedNCT03110731Not applicable
- Improving the Assessment of HypersomnolenceCompletedNCT02884505
- Pitolisant (BF2.649) in the Treatment of EDS in Patients With OSACompletedNCT02739568Phase 3
- Varenicline Treatment for Excessive Daytime Sleepiness in Parkinson's DiseaseTerminatedNCT02473562Phase 4
- The Efficacy and Tolerability of Modafinil for Fatigue and Daytime Sleepiness in Cancer Patients: Preliminary StudyStatus unknownNCT02385656Phase 4
- CPAP to Reduce Arterial Stiffness in Non Sleepy, Moderate to Severe Obstructive Sleep Apnea (STIFFSLEEP)TerminatedNCT02273089
- A Phase 1, Single Dose Study of JZP-386 to Evaluate Safety, Pharmacokinetics and PharmacodynamicsCompletedNCT02215499Phase 1
- Simulated Dawn Med StudentsCompletedNCT02088593Not applicable
- Sleep Quality, Daytime Sleepiness and Insomnia in Patients With Endometriosis: a Case-control Study.CompletedNCT02027142
- Post-prandial Hypotension and Sleepiness in Parkinson's Disease and Other SynucleinopathiesCompletedNCT02021903Not applicable
- Sleepiness and Sleep-disordered Breathing in Fabry Disease. A Prospective Cohort Study.CompletedNCT01947634Not applicable
- Pitolisant to Assess Weekly Frequency of Cataplexy Attacks and EDS in Narcoleptic Patients (HARMONY CTP)CompletedNCT01800045Phase 3
- Palliative Morphine With or Without Concurrent ModafinilStatus unknownNCT01766323Phase 3
- An Educational Intervention to Promote Safe DrivingCompletedNCT01697189Not applicable
- Objective Assessment of the Effects of Shift Work on Drowsiness and Driving Impairment in Hospital StaffActive, not recruitingNCT01672489
- Effects of BF2.649 in the Treatment of Excessive Daytime Sleepiness in Narcolepsy.CompletedNCT01638403Phase 3
- Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Armodafinil in Children and Adolescents With Excessive Sleepiness Associated With NarcolepsyCompletedNCT01624480Phase 1
- Dose-range Finding Study of BF2.649 Effect on Patients With Obstructive Sleep Apnea (OSA)CompletedNCT01620554Phase 2
- NAPS-MS: NAtalizumab Effects on Parameters of Sleep in Patients With Multiple Sclerosis Experiencing Fatigue or SleepinessCompletedNCT01591551Phase 4
- Comparison of RT in Patients With Sleep Apnea With and Without Complaints of Daytime SleepinessStatus unknownNCT01562262
- Structured Physical Activity for Sleep Quality and Daytime Sleepiness in Patients With Parkinson's DiseaseTerminatedNCT01544465Not applicable
- Acupressure for Persistent Cancer Related FatigueCompletedNCT01281904Phase 2/3
- Study of Sleep Habits and Prevalence of Sleepiness in a Health Care Environment in BarcelonaCompletedNCT01175304
- Sleepiness and Driving Performances in Adults With Attention-Deficit/ Hyperactivity Disorder (ADHD)CompletedNCT01160874Not applicable
- Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study of ABT-652 in Subjects With Excessive Daytime SleepinessCompletedNCT01124851Phase 1
- BF2.649 in Patients With OSA, Still Complaining of EDS and Refusing to be Treated by CPAP.CompletedNCT01072968Phase 3
- BF2.649 in Patients With OSA and Treated by CPAP But Still Complaining of EDSCompletedNCT01071876Phase 3
- Effect of Countermeasures on Nocturnal Driving PerformanceCompletedNCT01070004Not applicable
- Efficacy and Safety Study of BF2.649 and BF2.649 Add on Modafinil on Cataplexy in Patients With NarcolespyCompletedNCT01067235Phase 3
- Efficacy and Safety Study of BF2.649 in the Treatment of Excessive Daytime Sleepiness in NarcolepsyCompletedNCT01067222Phase 3
- Efficacy and Safety of BF2.649 in Excessive Daytime Sleepiness (EDS) in Parkinson's DiseaseCompletedNCT01066442Phase 3
- Face of SleepinessCompletedNCT01060436
- Efficacy and Safety of BF2.649 in Excessive Daytime Sleepiness (EDS) in Parkinson's DiseaseCompletedNCT01036139Phase 3
- Energy Drinks & Driving AbilityCompletedNCT01007877Not applicable
- Study of Modafinil to Treat Fatigue in Persons With Traumatic Brain InjuryCompletedNCT00702637Phase 1
- Sleepiness and Brain Function: The Effect of Armodafinil in Shift Work Sleep DisorderCompletedNCT00688142
- Dose Range Finding Study of BF2.649 Versus Placebo to Treat Excessive Daytime Sleepiness in Parkinson's Disease PatientsCompletedNCT00642928Phase 2
- Cost/Effectiveness Analysis of the Respiratory Poligraphy at HomeCompletedNCT00614952Not applicable
- Use of Armodafinil for Fatigue in SarcoidosisCompletedNCT00555347Phase 2/3
- Modafinil Augmentation Therapy for Excessive Daytime Sleepiness and Negative Symptoms in Patients With SchizophreniaCompletedNCT00546403Not applicable
- Naps and Pulses of Bright Light in Shift WorkersCompletedNCT00487292Not applicable
- Effects From a Mandibular Repositioning Appliance in Patients With Obstructive Sleep Apnea and SnoringCompletedNCT00477009Not applicable
- VSF-173 Study in Healthy Adult Volunteers for Treatment of Induced Excessive SleepinessCompletedNCT00467441Phase 2
- Caffeine for Excessive Daytime Somnolence in Parkinson's DiseaseCompletedNCT00459420Phase 2/3
- Efficacy Study of EVT 201 in the Treatment of Elderly Patients With Daytime SleepinessCompletedNCT00401284Phase 2
- Comparison of Modafinil and Methylphenidate in Treatment of Excessive Daytime Sleepiness in Patients With Parkinson's DiseaseWithdrawnNCT00393562Not applicable
- Sedating Antidepressant Improves Driving Safety in Patients With Major Depressive DisorderCompletedNCT00385437Phase 2
- Study of Pantoprazole for Sleepiness Associated With Acid Reflux and Sleep ApneaCompletedNCT00307944Phase 4
- LAP-BAND Observational CohortStatus unknownNCT00283972
- Assess the Safety and Effectiveness of PROVIGIL Treatment in Children and Adolescents With Excessive SleepinessCompletedNCT00214968Phase 3
- Provigil in Conjunction With SSRIs for the Treatment of Mild or Moderate Depression With Attendant Symptoms of Sleepiness and Fatigue.CompletedNCT00208715Phase 4
- Provigil (Modafinil) Study by Taiwan Biotech Co.CompletedNCT00174174Not applicable
- Effect of Continuous Positive Airway Pressure (CPAP) on Hypertension and Cardiovascular Morbidity-Mortality in Patients With Sleep Apnea and no Daytime SleepinessCompletedNCT00127348Phase 4
- PROVIGIL® (Modafinil) Treatment in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy or Obstructive Sleep Apnea/Hypopnea SyndromeCompletedNCT00107848Phase 3
- Study of PROVIGIL ® (Modafinil) Treatment in Children and Adolescents With Excessive Sleepiness Associated With Obstructive Sleep Apnea/Hypopnea SyndromeCompletedNCT00107809Phase 3
- Study of PROVIGIL ® (Modafinil) Treatment in Children and Adolescents With Excessive Sleepiness Associated With NarcolepsyCompletedNCT00107796Phase 3